|Home | About | Journals | Submit | Contact Us | Français|
During apoptosis, dying cells are swiftly removed by phagocytes. How apoptotic cells are recognized by phagocytes is not fully understood. Here we report the identification and characterization of the C. elegans ttr-52 gene, which is required for efficient cell corpse engulfment and encodes a transthyretin-like protein. The TTR-52 protein is expressed in and secreted from C. elegans endoderm and clusters around apoptotic cells. Genetic analysis indicates that TTR-52 acts in the cell corpse engulfment pathway mediated by CED-1, CED-6, and CED-7 and affects clustering of the phagocyte receptor CED-1 around apoptotic cells. Interestingly, TTR-52 recognizes surface exposed phosphatidylserine (PS) in vivo and binds to both PS and the extracellular domain of CED-1 in vitro. Therefore, TTR-52 is the first bridging molecule identified in C. elegans that mediates recognition of apoptotic cells by cross-linking the PS “eat me” signal with the phagocyte receptor CED-1.
Phagocytosis and removal of apoptotic cells is an important event in tissue remodeling, suppression of inflammation, and regulation of immune responses1,2. During apoptosis, apoptotic cells expose various “eat-me” signals, which are recognized by phagocytes either directly through phagocyte receptors or indirectly through bridging molecules that cross-link apoptotic cells to phagocytes3. The recognition of “eat-me” signals by phagocytes triggers signaling cascades, leading to internalization and degradation of apoptotic cells by phagocytes3.
In C. elegans, phagocytosis of apoptotic cells is controlled by two partially redundant signaling pathways4. In one pathway, several conserved intracellular signaling molecules, CED-2/CrkII, CED-5/DOCK180, and CED-12/ELMO, mediate the activation of the small GTPase CED-10/Rac1, leading to cytoskeleton reorganization needed for phagocytosis5–9. In the other pathway, three genes, ced-1, ced-6 and ced-7, are involved in recognizing and transducing “eat-me” signals. ced-1 encodes a single-pass transmembrane protein that acts in engulfing cells to promote removal of apoptotic cells10. The CED-1::GFP fusion is found to cluster specifically around apoptotic cells10, indicating that CED-1 plays a role in recognizing apoptotic cells. CED-1 shares sequence similarity with several mammalian cell surface proteins, including Scavenger Receptor from Endothelial Cells, LRP/CD91, and MEGF10 (multiple EGF-like-domains 10), and two Drosophila proteins, Draper and Six-microns-under (SIMU), all of which have been implicated in phagocytosis of apoptotic cells10–15. Some, like CED-1, are involved in recognition of apoptotic cells14,16. MEGF10 can partially substitute for the function of CED-1 in C. elegans12. Therefore, CED-1 defines a conserved family of phagocyte receptors important for recognition and removal of apoptotic cells.
How CED-1 family proteins recognize apoptotic cells is not clear. One potential signal recognized by CED-1 is phosphatidylserine (PS) exposed on the surface of apoptotic cells, which has been shown to be a conserved “eat-me” signal17,18. Indeed, PS is detected on the surface of most C. elegans apoptotic cells and found to be important for cell corpse engulfment19–22. In animals lacking TAT-1, an aminophospholipid translocase that maintains plasma membrane PS asymmetry, PS is ectopically exposed on the surface of normal cells, which triggers removal of normally cells in a CED-1-dependent manner22. Therefore, CED-1 may recognize and mediate removal of cells with surface exposed PS. However, CED-1 or its homologues are not known to bind PS directly and may recognize PS through an intermediate molecule.
Here we report the identification of a secreted protein, TTR-52, that binds surface exposed PS on the apoptotic cell and the CED-1 receptor and acts as a bridging molecule to mediate recognition and engulfment of apoptotic cells by the CED-1 bearing phagocytes.
In a genetic screen for mutations that enhance the weak engulfment defect of the psr-1(tm469) mutant (see Methods), which lacks the PS-recognizing PSR-1 receptor23, we isolated a recessive mutation (sm211) that not only enhances the psr-1 engulfment defect but also results in increased cell corpses on its own (Fig. 1a, b). In fact, the numbers of cell corpses observed in the sm211 mutant at all embryonic stages and the L1 larval stage are significantly higher than those of the wild-type or psr-1(tm469) animals (Fig. 1a, b).
To determine whether sm211 animals are defective in cell corpse engulfment, we performed a time-lapse analysis to measure the durations of cell corpses in wild type and sm211 animals23. The majority of cell corpses in wild-type animals persisted from 10 to 40 minutes, with an average duration of 28 minutes (Fig. 1c). In contrast, most cell corpses in sm211 embryos lasted from 30 to 110 minutes, with an average duration almost twice as long (55 minutes; Fig. 1c), indicating that cell corpse engulfment is compromised. Similar delayed and compromised cell corpse engulfment was observed in the sm211 mutant in three specific cells (C1, C2, and C3; Fig. 1d), which are programmed to die at the mid-embryonic stage24. We also counted the number of nuclei in the anterior pharynx of sm211 animals (see Methods) and found that they do not have any normally living cells missing or undergoing ectopic apoptosis in this region. Instead, a few cells that normally are programmed to die inappropriately survived in some sm211 animals (Supplementary Information, Table S1), suggesting that sm211 actually promotes cell survival. Indeed, sm211 significantly enhances the cell death defect of the weak ced-3 or ced-4 loss-of-function (lf) mutants (Table S1), a phenomenon also observed with many engulfment-defective mutations such as ced-1(lf) mutations25,26. Taken together, these results indicate that the cell corpse engulfment process is severely compromised in the sm211 mutant.
We analyzed double mutants containing sm211 and strong lf mutations in genes involved in cell corpse engulfment to determine the engulfment pathway in which the gene affected by sm211 acts. sm211 specifically enhanced the engulfment defect conferred by mutations in the ced-2, ced-5, ced-10 and ced-12 genes, which act in one pathway, but not that caused by mutations in the ced-1, ced-6 and ced-7 genes, which act in a different engulfment pathway (Fig. 1e). These results indicate that the gene affected by sm211 likely functions in the same corpse engulfment pathway as ced-1, ced-6 and ced-7.
We mapped sm211 very close to the bli-5 gene on Linkage Group III (Fig. 2a; see Methods). Transformation rescue experiments revealed that one cosmid in the mapped region, F11F1, fully rescued the engulfment defect of the sm211 mutant. Subclones of F11F1 were made and a 3.7 kb Bam HI-Nhe I genomic fragment was capable of rescuing the sm211 mutant (Fig. 2a). There is only one gene in this region, ttr-52 (Transthyretin-related family domain), which encodes a 135 amino-acid protein that shares limited sequence similarity to transthyretin (Fig. 2b), a thyroid hormone-binding protein found in the blood of vertebrates27. TTR-52 is one of the 57 transthyretin-like proteins in C. elegans28,29, all of which contains a transthyretin-like domain (PF01060)(Supplementary Information, Fig. S1). The biological functions of this gene family are unknown and most are predicted to encode secretory proteins (Supplementary Information, Table S2). We identified a G to A transition in the ttr-52 gene from the sm211 mutant, which results in substitution of Val 43 by Met, a conserved residue among worm TTR proteins and human transthyretin (Fig. 2b and Supplementary Information, Fig. S1). Expression of a full-length ttr-52 cDNA under the control of several different C. elegans gene promoters fully rescued the sm211 mutant (Fig. 2a), confirming that ttr-52 is the gene affected by sm211.
Protein sequence analysis reveals that TTR-52 contains a secretion signal at its amino-terminus (Fig. 2b). To determine the cellular localization pattern of TTR-52, we expressed a TTR-52 GFP fusion under the control of the C. elegans heat-shock promoters (PhspTTR-52::GFP), which fully rescues the engulfment defect of the ttr-52(sm211) mutant (Fig. 2c). Upon heat-hock treatment, TTR-52::GFP was detected almost exclusively on the surface of apoptotic cells, displaying a bright ring-like staining (Fig. 2c and Fig. 3a). In some embryos, weak GFP staining was also observed on the surface of cells adjacent to the dying cells (Supplementary Information, Fig. S2a). Since heat-shock promoters induce global gene expression in C. elegans embryos, this unique, restricted TTR-52 localization pattern indicates that TTR-52 may be a secretory protein that binds rather specifically to the surface of apoptotic cells. Expression of a TTR-52::mCHERRY (monomeric Cherry) fusion under the control of the heat-shock promoters or the ttr-52 promoter resulted in the same staining pattern (Fig. 3b). The staining of TTR-52::mCHERRY or TTR-52::GFP on the surface of dying cells was abolished by a loss-of-function mutation in the ced-3 gene (n717)(Fig. 3d; data not shown), which blocks almost all apoptosis in C. elegans30, confirming that the cells labeled by TTR-52 were apoptotic cells.
To confirm that TTR-52 is a secretory protein, we generated two mutant TTR-52::GFP fusions, TTR-52(21-135)::GFP and TTR-52(F11D, F12D)::GFP, and expressed them under the control of heat-shock promoters (Fig. 2c and Supplementary Information, Fig. S3). The first one lacks the predicted secretion signal (amino acids 1-20) and the latter contains mutations altering two hydrophobic residues in the signal peptide predicted to be critical for the secretion of the protein (SignalP 3.0 program, www.cbs.dtu.dk/services/SignalP/). In embryos expressing these two mutant TTR-52::GFP fusions, the surface of apoptotic cells was not labeled by GFP. Instead, diffused GFP was observed in the cytosol and nucleus of both apoptotic and non-apoptotic cells, indicating that they are not secreted (Fig. 3c, e and Supplementary Information, Fig. S4a, b). We observed a similar GFP staining pattern with TTR-52::GFP carrying the V43M mutation found in the sm211 mutant (Fig. 3f and Supplementary Information, Figs. S3e, S4c). All three TTR-52::GFP fusions failed to rescue the engulfment defect of the ttr-52(sm211) mutant (Fig. 2c). Therefore, TTR-52 needs to be secreted to function.
We also tested whether TTR-52 could function properly when tethered to the cell surface. We generated a transmembrane TTR-52::GFP fusion (TTR-52::TM::GFP) by inserting the transmembrane domain of CED-1 between TTR-52 and GFP and expressed this fusion in either engulfing cells or dying cells under the control of the ced-1 or egl-1 promoter (Fig. 2c)10,31. In embryos transgenic for Pced-1TTR-52::TM::GFP or Pegl-1TTR-52::TM::GFP, the GFP fusion was found on the surface of normal cells and dying cells, respectively (Fig. 2c, Supplementary Information, Fig. S2c, and data not shown). However, TTR-52::TM::GFP expressed in engulfing cells did not cluster around apoptotic cells like TTR-52::GFP (Supplementary Information, Fig. S2c), suggesting that membrane tethering affects or interferes with recognition of apoptotic cells by TTR-52. Indeed, neither of the constructs alone nor in combination rescued the engulfment defect of the ttr-52(sm211) mutant (Fig. 2c; data not shown). In comparison, expression of TTR-52 under the control of the same promoters (Pced-1TTR-52 or Pegl-1TTR-52) fully rescued the ttr-52 (sm211) mutant (Fig. 2a), indicating that the membrane-tethered TTR-52 cannot substitute for a secreted TTR-52.
To examine where ttr-52 is expressed in C. elegans, we generated a ttr-52 transcriptional fusion with mCHERRY (Pttr-52mCHERRY) and found that the ttr-52 promoter drove mCHERRY expression specifically in intestine cells, which completely overlapped with the GFP expression pattern of Pges-1GFP, an intestine-specific reporter construct (Fig. 3g)32. Therefore, the intestine cells, which do not undergo programmed cell death in C. elegans33,34, synthesize TTR-52, which likely is secreted, diffuses, and binds to apoptotic cells, promoting their engulfment by neighboring phagocytes. Consistent with this notion, when TTR-52::mCHERRY and GFP were co-expressed under the control of the endogenous ttr-52 promoter (Pttr-52TTR-52::mCHERRY and Pttr-52GFP), GFP expression was restricted to the gut, whereas TTR-52::mCHERRY was seen mostly outside the gut region, labeling apoptotic cells that either were close to or away from the gut (Supplementary Information, Fig. S2d).
ced-1 encodes a phagocyte receptor that clusters around apoptotic cells through an unknown mechanism10. The observations that TTR-52, a secreted protein, similarly clusters around apoptotic cells and acts in the same engulfment pathway as CED-1 suggest that TTR-52 may function to mediate recognition of dying cells by CED-1. Indeed, in a strain expressing both TTR-52::mCHERRY (PhspTTR-52::mCHERRY) and CED-1::GFP (Pced-1CED-1::GFP), TTR-52::mCHERRY frequently co-localized with CED-1::GFP, as 69% of apoptotic cells clustered by CED-1::GFP were also surrounded by TTR-52::mCHERRY (n=183). TTR-52::mCHERRY and CED-1::GFP either formed an overlapping mCHERRY/GFP ring around the apoptotic cell (indicated by an arrow, Fig. 4a) or a mCHERRY/GFP ring inside a larger CED-1::GFP ring, indicative of an internalized apoptotic cell in a phagocyte (indicated by an arrowhead, Fig. 4a). TTR-52::mCHERRY rings were also seen alone (indicated by a blue arrowhead, Fig. 4a) or accompanied by a partial or incomplete CED-1::GFP ring (Fig. 5, b–e), indicating that formation of the TTR-52::mCHERRY ring precedes the formation of CED-1::GFP ring on apoptotic cells. By time-lapse microscopy analysis, we observed that a complete TTR-52::mCHERRY ring was formed rapidly around the dying cell early during apoptosis (indicated by an arrowhead, Fig. 5b), whereas only trace amounts of CED-1::GFP were seen nearby (indicated by an arrow, Fig. 5b). CED-1::GFP continued to circularize (Fig. 5, c–e) and reached a complete circle overlapping with the TTR-52::mCHERRY ring within 30 minutes (Fig. 5f). In 37 apoptotic cells from 8 embryos that we monitored, the TTR-52::mCHERRY ring was always formed prior to the CED-1::GFP ring, indicating that TTR-52 may induce the formation of the CED-1::GFP ring around apoptotic cells.
We thus examined whether loss of ttr-52 affects clustering of CED-1::GFP around apoptotic cells by analyzing C. elegans embryos expressing CED-1::GFP (smIs34: Pced-1ced-1::gfp). Approximately 64% of cell corpses were labeled by CED-1::GFP in wild-type 1.5-fold stage embryos. By contrast, in smIs34; ttr-52(sm211) 1.5-fold embryos, only half (34%) of the cell corpses were labeled (Fig. 4b), indicating that TTR-52 is important for mediating the clustering of CED-1 around apoptotic cells. Since clustering of apoptotic cells by TTR-52::mCHERRY was not affected by loss of ced-1 (Fig. 4c), these results indicate that TTR-52 is independent of and precedes CED-1 in binding to apoptotic cells.
We examined whether TTR-52 directly interacts with CED-1 in vitro, using a Glutathione-S-Transferase (GST) fusion protein pull down assay. Recombinant TTR-52 interacted with purified GST-CED-1(Extra), which contains the extracellular domain of CED-1, but not with either GST or GST-CED-1(Intra), which contains the intracellular domain of CED-1 (Fig. 4d). None of these GST fusion proteins bound SYCT (specific Yop chaperone), a control protein, suggesting that TTR-52 interacts specifically with the extracellular domain of CED-1. We also examined the interaction of TTR-52 with CED-1 by co-immunoprecipitation (co-IP) assays using a C. elegans strain that co-expressed CED-1::GFP from smIs34 and TTR-52::FLAG and SUR-5::GFP from a second integrated transgene smIs118 (carrying both PhspTTR-52::FLAG and Psur-5SUR-5::GFP)(Fig. 4e, lane 1). Using an antibody to the FLAG epitope, CED-1::GFP but not SUR-5::GFP was specifically co-precipitated with TTR-52::FLAG (Fig. 4e, lanes 2–3). Together, these results indicate that TTR-52 interacts specifically with the CED-1 receptor to mediate recognition and binding of apoptotic cells by CED-1.
To identify the apoptotic cell signal recognized by TTR-52, we performed a genetic screen to search for mutations that altered the staining of TTR-52::mCHERRY to apoptotic cells. One mutation, qx30, resulted in TTR-52::mCHERRY staining of virtually all cells in qx30 mutant embryos, including non-apoptotic cells that normally are not labeled by TTR-52 (Fig. 6a, b). qx30 turns out to be an allele of tat-1 (see Methods), which encodes an aminophospholipid translocase that prevents appearance of PS in the outer leaflet of plasma membrane22. Because in tat-1(lf) animals PS is ectopically exposed on the surface of many living cells22, this unexpected finding suggests that TTR-52 may bind surface-exposed PS.
We employed a yeast-based PS binding assay35 to test the binding of TTR-52 to PS. In this assay, the C2 domain of lactadherin (Lact-C2), which binds specifically to PS36, associates predominantly with plasma membrane that contains PS in its inner leaflet in wild-type yeast cells (Fig. 6d)35. In cho1 mutant cells that are deficient in PS synthesis, GFP::Lact-C2 becomes cytosolic (Fig. 6e), due to loss of PS in yeast plasma membrane35. Like GFP::Lact-C2, TTR-52::mCHERRY labeled plasma membrane in wild-type yeast cells but failed to do so in the cho1 cells (Fig. 6f, g), indicating that TTR-52 binds PS in plasma membrane.
To identify the region of TTR-52 important for PS binding, we generated several TTR-52 mutants with mutations or small deletions (data not shown). One mutant, TTR-52(M5), in which residues 50-55 were replaced by Alanines, failed to associate with yeast plasma membrane (Fig. 2b; Fig. 6h), presumably due to loss of PS binding. In vivo, TTR-52(M5)::mCHERRY failed to rescue the engulfment defect of the ttr-52(sm211) mutant and did not cluster around apoptotic cells in wild-type embryos (Fig. 2c, Fig. 6c, and Supplementary Fig. 3i), although it was secreted normally and accumulated in embryo cavity.
We also examined whether TTR-52 directly binds PS and apoptotic cells. Recombinant TTR-52::mCHERRY::FLAG was purified from human 293T cells and tested for binding to a membrane strip spotted with 16 different phospholipids (see Methods). TTR-52 showed strong and specific binding to PS but not to other phospholipids such as PC, PE, PA and various phosphoinositides, with the exception of a weak binding to PtdIns(4)P (Fig. 6i). In contrast, the binding of TTR-52::mCHERRY(M5)::FLAG to PS was barely detectable. Thus, TTR-52 binds specifically to PS in vitro.
When we incubated purified TTR-52::mCHERRY::FLAG with dissected gonads from animals treated with gla-3 RNAi that causes increased germ cell deaths37, TTR-52::mCHERRY labeled specifically apoptotic germ cells on the surface of the dissected gonad (Fig. 6j)19. This TTR-52 labeling was abolished by the ced-3(n717) mutation (Fig. 6k), indicating that TTR-52 binds apoptotic germ cells. TTR-52::mCHERRY also stained many germ cells in the tat-1(qx30) mutant (Fig. 6l), in which PS is ectopically exposed on the surface of normal germ cells22. In contrast, purified TTR-52(M5)::mCHERRY failed to label apoptotic germ cells in gla-3(RNAi) animals and normal germ cells in the tat-1(qx30) mutant (Fig. 6m, n). Taken together, these results indicate that TTR-52 binds surface exposed PS, and as such, mediates recognition of apoptotic cells by the phagocyte receptor CED-1.
One physiological consequence of ectopic PS exposure on the surface of normal cells in tat-1(lf) animals is random removal of these cells through a CED-1-dependent phagocytic mechanism22. For example, in bzIs8 animals, six touch-receptor neurons are labeled by GFP expressed from the Pmec-4GFP construct carried by the integrated bzIs8 transgene and none of the bzIs8 animals lost touch cells (Fig. 7a). By contrast, 15–16% of tat-1(qx30); bzIs8 or tat-1(tm1034); bzIs8 animals lost at least one touch cell. This missing cell phenotype was strongly suppressed by the ced-1(e1735) mutation (Fig. 7a), suggesting that CED-1 recognizes and mediates removal of cells with surface-exposed PS. Interestingly, the missing cell phenotype of the tat-1(lf) mutants was also strongly suppressed by ttr-52(sm211) (Fig. 7a), despite being a weaker engulfment-blocking mutation than ced-1(e1735). This result suggests that TTR-52 solely mediates recognition of surface exposed PS by CED-1, which could be the only engulfment signal expressed by touch cells in tat-1(lf) animals. Consistent with this finding, TTR-52::mCHERRY labeled the surface of touch cells in tat-1(tm1034); bzIs8 animals, but not touch cells in bzIs8 animals (Fig. 7b).
How the CED-1 family of phagocyte receptors recognizes apoptotic cells is unknown and is a subject of intense study. In this study, we identify a new gene, ttr-52, that encodes a secretory protein and acts specifically in the CED-1 signaling pathway to mediate engulfment of apoptotic cells in C. elegans. Interestingly, the secreted TTR-52 protein clusters around apoptotic cells and precedes CED-1 in binding to apoptotic cells in vivo. Moreover, TTR-52 is important for efficient binding of CED-1 to apoptotic cells and interacts specifically with the extracellular domain of CED-1. These findings together provide strong evidence that TTR-52 is a new extracellular bridging molecule that mediates the binding and recognition of apoptotic cells by the phagocyte receptor CED-1.
How does CED-1 or TTR-52 recognize apoptotic cells? We found that TTR-52 binds plasma membrane PS in a yeast-based PS binding assay (Fig. 6f, g) and binds PS specifically in vitro (Fig. 6i), indicating that it is a PS-binding protein. Moreover, recombinant TTR-52 labeled specifically apoptotic germ cells and the surface of many germ cells in the tat-1(lf) mutant ex vivo (Fig. 6j–l), providing direct evidence that TTR-52 recognizes and binds surface exposed PS. A TTR-52 mutant, TTR-52(M5), that fails to bind PS in vitro (Fig. 6i), loses its ability to bind apoptotic cells in C. elegans and its activity to rescue the engulfment defect of the ttr-52(sm211) mutant (Fig. 2 and Fig. 6), indicating that the ability to bind PS is critical for TTR-52’s function in phagocytosis. Like CED-1, TTR-52 is required for removing normal cells with inappropriately exposed PS in the tat-1(lf) mutants (Fig. 7), which presumably do not express other “eat-me” signals seen on the surface of apoptotic cells22. Therefore, TTR-52 most likely recognizes and binds surface exposed PS to mediate cell corpse engulfment. Given that surface exposed PS is the only conserved engulfment signal identified thus far in multiple organsims18, it may serve as a conserved recognition signal for the CED-1 receptor family.
In mammals, extracellular bridging molecules such as thrombospondin (TSP), β2 glycoprotein I, and the collectin family proteins38–44, some of which recognize and bind surface exposed PS, play an important role in cross-linking apoptotic cells to macrophages, which often are not in close contact with their targets. For invertebrate animals such as Drosophila and C. elegans, it is unclear whether bridging molecules are needed to mediate removal of apoptotic cells, especially in C. elegans, where phagocytes are neighboring cells already in close contact with apoptotic cells. Our finding that TTR-52, an extracellular bridging protein, is important for mediating recognition and binding of apoptotic cells by the CED-1 phagocyte receptor suggests that this is a conserved and important mechanism for clearance of apoptotic cells, although the identities of bridging molecules could differ significantly across the species.
TTR-52 is a member of the transthyretin-like protein family, a subfamily of the larger transthyretin-related protein family (TRPs) that has sequence and structural similarity with transthryretin in the signature transthyretin-like domain and that has been found in a broad range of species, including bacteria, plants, invertebrates, and vertebrates45,46. The functions of TRPs are largely unknown, although some have been implicated in purine catabolism in mice and regulation of the brassinosteroid receptor in plants45–48. There are 57 transthyretin-like proteins in C. elegans, whose biological functions have not been characterized. TTR-52 is the first of this protein family with a clearly defined cellular function. Since many of the nematode transthyretin-like proteins are predicted to be secretory proteins (Supplementary Information, Table S2), it seems likely that one potential important function of this protein family is to act extracellularly to mediate cell-cell interaction, although individual RNAi knockdown of 57 worm transthyretin-like genes, including ttr-52, fails to reveal an obvious defect (data not shown). Since ttr-52(sm211) only partially blocks the clustering of CED-1 around apoptotic cells and causes a weaker engulfment defect than ced-1(lf) mutations, additional bridging molecule(s) and/or “eat-me” signal(s) could act in parallel to TTR-52 to mediate recognition of apoptotic cells by CED-1. Furthermore, given the presence of multiple PS-recognizing receptors in mammals49, additional PS-recognizing receptors, including PSR-123, could act in parallel to TTR-52/CED-1 in C. elegans to mediate removal of apoptotic cells with surface exposed PS.
Methods and associated references are available in the online version of the paper.
We thank J. McGhee for the Pges-1gfp construct and T. Blumenthal for comments and discussion on the manuscript. This work was supported by a Burroughs Wellcome Fund Award (D.X.), NIH R01 grants GM59083 and GM79097 (D.X.), and the National High Technology Project 863 of China (X.C.W).
AUTHOR CONTRIBUTIONSX.C.W. and W.D.L. performed most of the genetic and cell biological experiments. D.F.Z. performed both PS-binding experiments and in vitro protein interaction assays. Y.S. performed immunoprecipitation experiments in C. elegans. B.L., B.H.C., P.F.G., and X.G. performed some of the genetic and cell biological experiments. H.W.Y. performed the initial in vitro PS binding experiments and E. P. did bioinformatic analysis of TTR family proteins. Z.H.S., E.K.N. and S.M. contributed to the generation of strains. X.C.W. and D.X. designed the experiments and wrote the paper.
COMPETING FINANCIAL INTERESTS
The authors declare no competing financial interests.